Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft

Artificial Organs

Volumn 30, Issue 12, 2006, Pages 898-905

  Zhang, Jun ^a   Qi, Hongxu ^b   Wang, Hongjun ^c   Hu, Ping ^b   Ou, Lailiang ^a   Guo, Shuhua ^a   Li, Jing ^a   Che, Yongzhe ^a   Yu, Yaoting ^a   Kong, Deling ^a  

^a NANKAI UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c STEVENS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bone marrow stem cells; Endothelial nitric oxide synthase; Gene therapy; Tissue engineering; Vascular graft

Indexed keywords

BLOOD VESSELS; BONE; CELL ENGINEERING; ELECTROSPINNING; FLOWCHARTING; FLUORESCENCE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GRAFTS; POLYMERASE CHAIN REACTION; PROPYLENE; PROTEINS; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY; STEM CELLS;

BONE MARROW MESENCHYMAL; BONE MARROW STEM CELLS; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENETICALLY MODIFIED; MARROW MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; POLYPROPYLENE CARBONATE; SYNTHASE GENE; TISSUES ENGINEERINGS; VASCULAR GRAFTS;

CELL CULTURE;

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GREEN FLUORESCENT PROTEIN; POLY (PROPYLENE CARBONATE); PROPYLENE CARBONATE;

ANIMAL CELL; ARTICLE; BLOOD VESSEL GRAFT; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DNA MODIFICATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; IMMUNOCHEMISTRY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

EID: 33845508675     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2006.00322.x     Document Type: Article

References (21)

1. Campbell CD, Goldfarb D, Roe R. A small arterial substitute: expanded microporous polytetrafluoroethylene: patency versus porosity. Ann Surg 1975;182:138-43.
2. Sandro L, Giovanni A, Vincenzo V, et al. In vivo regeneration of small-diameter (2 mm) arteries using a polymer scaffold. FASEB J 2006;20:103-5.
3. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986;231:397-400.
4. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998;12:47-56.
5. Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vitro. Science 1999;284:489-93.
6. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7:1035-40.
7. Cho SW, Lim SH, Kim IK, et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005;241:506-15.
8. Cho SW, Park HJ, Ryu JH, et al. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices. Biomaterials 2005;26:1915-24.
9. Kanki HS, Horimoto H, Mieno S, et al. Synthetic vascular prosthesis impregnated with genetically modified bone marrow cells produced recombinant proteins. Artif Organs 2005;29:815-19.
10. Pearson PJ, Evora PR, Schaff HV. Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. J Thorac Surg 1992;54:1078-84.
11. Shapira OM, Xu A, Aldea GS, Vita JA, Shemin RJ, Keaney JF Jr. Enhanced nitric oxide-mediated vascular relaxation in radial artery compared with internal mammary artery or saphenous vein. Circulation 1999;100:322-7.
12. Kong D, Melo LG, Mangi AA, et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004;109:1769-75.
13. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995;92:1137-41.
14. Yu H, Dai W, Yang Z, Romaguera RL, Kirkman P, Rowe VL. Neointimal hyperplasia on a cell-seeded polytetrafluoroethylene graft is promoted by transfer of tissue plasminogen activator gene and inhibited by transfer of nitric oxide synthase gene. J Vasc Surg 2005;41:122-9.
15. Chisholm MH, Navarro-Llobet D, Zhou Z. Poly(propylene carbonate). 1. More about Poly(propylene carbonate) formed from the copolymerization of propylene oxide and carbon dioxide employing a zinc glutarate catalyst. Macromolecules 2002;35:6494-504.
16. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-201.
17. Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 1996;93:11400-6.
18. Xu C, Inai R, Kotaki M, Ramakrishna S. Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng 2004;10:1160-8.
19. Ma Z, Kotaki M, Inai R, Ramakrishna S. Potential of nanofiber matrix as tissue-engineering scaffolds. Tissue Eng 2005;11:101-9.
20. Rosenman JE, Kempczinski RF, Pearce WH, Silberstein EB. Kinetics of endothelial cell seeding. J Vasc Surg 1985;2:778-84.
21. Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995;95:1747-55.